APO Research
Talk to an analyst

APO RESEARCH · REPORT

Third Party Clinical Testing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Third Party Clinical Testing Industry Growth and Trends Forecast to 2032

2 May 2026112 pages

Choose your research edition.

Industry ResearchThird Party Clinical Testing Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Third Party Clinical Testing Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Third Party Clinical Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Third Party Clinical Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Third Party Clinical Testing Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

According to APO Research, the global Third Party Clinical Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Third Party Clinical Testing market include Labcorp, IQVIA, PAREXEL International Corporation, ICON Plc, Charles River Laboratories, Syneos Health, PPD (Pharmaceutical Product Development), Medpace and WuXi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Third Party Clinical Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Third Party Clinical Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Third Party Clinical Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Third Party Clinical Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Third Party Clinical Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Third Party Clinical Testing Market by Company

Labcorp

IQVIA

PAREXEL International Corporation

ICON Plc

Charles River Laboratories

Syneos Health

PPD (Pharmaceutical Product Development)

Medpace

WuXi AppTec

Kingmed

Dian Diagnostics

Adicon Clinical Laboratories

Kindstar

DaAn Gene

Berry Genomics

Frontage Holdings

Centre Testing International

Shanghai Labway Clinical Laboratory

Third Party Clinical Testing Segment by Type

Biochemical Tests

Immunity Tests

Routine Blood Tests

Others

Third Party Clinical Testing Segment by Application

Personal

Enterprise

Third Party Clinical Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Third Party Clinical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Third Party Clinical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Third Party Clinical Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Third Party Clinical Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Third Party Clinical Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Third Party Clinical Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Third Party Clinical Testing Market Share by Region (2021-2026) Table 4. Global Third Party Clinical Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Third Party Clinical Testing Market Share by Region (2027-2032) Table 6. Global Third Party Clinical Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Third Party Clinical Testing Market Size Share by Type (2021-2026) Table 9. Global Third Party Clinical Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Third Party Clinical Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Third Party Clinical Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Third Party Clinical Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Third Party Clinical Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Third Party Clinical Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Third Party Clinical Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Third Party Clinical Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Third Party Clinical Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Third Party Clinical Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Third Party Clinical Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Third Party Clinical Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Third Party Clinical Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Third Party Clinical Testing Market Size Share by Application (2021-2026) Table 24. Global Third Party Clinical Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Third Party Clinical Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Third Party Clinical Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Third Party Clinical Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Third Party Clinical Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Third Party Clinical Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Third Party Clinical Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Third Party Clinical Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Third Party Clinical Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Third Party Clinical Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Third Party Clinical Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Third Party Clinical Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Third Party Clinical Testing Industry Trends Table 37. Third Party Clinical Testing Industry Drivers Table 38. Third Party Clinical Testing Industry Opportunities and Challenges Table 39. Third Party Clinical Testing Industry Restraints Table 40. Global Third Party Clinical Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Third Party Clinical Testing Revenue Market Share by Company (2021-2026) Table 42. Global Third Party Clinical Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Third Party Clinical Testing Key Company Headquarters & Area Served Table 44. Global Third Party Clinical Testing Company, Product Type & Application Table 45. Global Third Party Clinical Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Third Party Clinical Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Labcorp Company Information Table 49. Labcorp Business Overview Table 50. Labcorp Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Labcorp Third Party Clinical Testing Product Portfolio Table 52. Labcorp Recent Development Table 53. IQVIA Company Information Table 54. IQVIA Business Overview Table 55. IQVIA Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. IQVIA Third Party Clinical Testing Product Portfolio Table 57. IQVIA Recent Development Table 58. PAREXEL International Corporation Company Information Table 59. PAREXEL International Corporation Business Overview Table 60. PAREXEL International Corporation Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. PAREXEL International Corporation Third Party Clinical Testing Product Portfolio Table 62. PAREXEL International Corporation Recent Development Table 63. ICON Plc Company Information Table 64. ICON Plc Business Overview Table 65. ICON Plc Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ICON Plc Third Party Clinical Testing Product Portfolio Table 67. ICON Plc Recent Development Table 68. Charles River Laboratories Company Information Table 69. Charles River Laboratories Business Overview Table 70. Charles River Laboratories Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Charles River Laboratories Third Party Clinical Testing Product Portfolio Table 72. Charles River Laboratories Recent Development Table 73. Syneos Health Company Information Table 74. Syneos Health Business Overview Table 75. Syneos Health Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Syneos Health Third Party Clinical Testing Product Portfolio Table 77. Syneos Health Recent Development Table 78. PPD (Pharmaceutical Product Development) Company Information Table 79. PPD (Pharmaceutical Product Development) Business Overview Table 80. PPD (Pharmaceutical Product Development) Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product Portfolio Table 82. PPD (Pharmaceutical Product Development) Recent Development Table 83. Medpace Company Information Table 84. Medpace Business Overview Table 85. Medpace Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Medpace Third Party Clinical Testing Product Portfolio Table 87. Medpace Recent Development Table 88. WuXi AppTec Company Information Table 89. WuXi AppTec Business Overview Table 90. WuXi AppTec Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. WuXi AppTec Third Party Clinical Testing Product Portfolio Table 92. WuXi AppTec Recent Development Table 93. Kingmed Company Information Table 94. Kingmed Business Overview Table 95. Kingmed Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Kingmed Third Party Clinical Testing Product Portfolio Table 97. Kingmed Recent Development Table 98. Dian Diagnostics Company Information Table 99. Dian Diagnostics Business Overview Table 100. Dian Diagnostics Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Dian Diagnostics Third Party Clinical Testing Product Portfolio Table 102. Dian Diagnostics Recent Development Table 103. Adicon Clinical Laboratories Company Information Table 104. Adicon Clinical Laboratories Business Overview Table 105. Adicon Clinical Laboratories Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Adicon Clinical Laboratories Third Party Clinical Testing Product Portfolio Table 107. Adicon Clinical Laboratories Recent Development Table 108. Kindstar Company Information Table 109. Kindstar Business Overview Table 110. Kindstar Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Kindstar Third Party Clinical Testing Product Portfolio Table 112. Kindstar Recent Development Table 113. DaAn Gene Company Information Table 114. DaAn Gene Business Overview Table 115. DaAn Gene Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. DaAn Gene Third Party Clinical Testing Product Portfolio Table 117. DaAn Gene Recent Development Table 118. Berry Genomics Company Information Table 119. Berry Genomics Business Overview Table 120. Berry Genomics Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Berry Genomics Third Party Clinical Testing Product Portfolio Table 122. Berry Genomics Recent Development Table 123. Frontage Holdings Company Information Table 124. Frontage Holdings Business Overview Table 125. Frontage Holdings Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Frontage Holdings Third Party Clinical Testing Product Portfolio Table 127. Frontage Holdings Recent Development Table 128. Centre Testing International Company Information Table 129. Centre Testing International Business Overview Table 130. Centre Testing International Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Centre Testing International Third Party Clinical Testing Product Portfolio Table 132. Centre Testing International Recent Development Table 133. Shanghai Labway Clinical Laboratory Company Information Table 134. Shanghai Labway Clinical Laboratory Business Overview Table 135. Shanghai Labway Clinical Laboratory Third Party Clinical Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product Portfolio Table 137. Shanghai Labway Clinical Laboratory Recent Development Table 138. North America Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Third Party Clinical Testing Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Third Party Clinical Testing Market Share by Country (2021-2026) Table 141. North America Third Party Clinical Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Third Party Clinical Testing Market Share Forecast by Country (2027-2032) Table 143. Europe Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Third Party Clinical Testing Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Third Party Clinical Testing Market Share by Country (2021-2026) Table 146. Europe Third Party Clinical Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Third Party Clinical Testing Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Third Party Clinical Testing Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Third Party Clinical Testing Market Share by Country (2021-2026) Table 151. Asia-Pacific Third Party Clinical Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Third Party Clinical Testing Market Share Forecast by Country (2027-2032) Table 153. Latin America Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Third Party Clinical Testing Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Third Party Clinical Testing Market Share by Country (2021-2026) Table 156. Latin America Third Party Clinical Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Third Party Clinical Testing Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Third Party Clinical Testing Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Third Party Clinical Testing Market Share by Country (2021-2026) Table 161. Middle East & Africa Third Party Clinical Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Third Party Clinical Testing Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Third Party Clinical Testing Product Image Figure 3. Global Third Party Clinical Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global Third Party Clinical Testing Market Share by Region: 2025 VS 2032 Figure 6. Global Third Party Clinical Testing Market Share by Region (2021-2032) Figure 7. North America Third Party Clinical Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Third Party Clinical Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Third Party Clinical Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Third Party Clinical Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Third Party Clinical Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Biochemical Tests Image Figure 13. Global Biochemical Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Immunity Tests Image Figure 15. Global Immunity Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Routine Blood Tests Image Figure 17. Global Routine Blood Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Third Party Clinical Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Third Party Clinical Testing Market Share by Type 2025 VS 2032 Figure 22. North America Third Party Clinical Testing Market Size Share by Type (2021-2032) Figure 23. Europe Third Party Clinical Testing Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Third Party Clinical Testing Market Size Share by Type (2021-2032) Figure 25. Latin America Third Party Clinical Testing Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Third Party Clinical Testing Market Size Share by Type (2021-2032) Figure 27. Personal Image Figure 28. Global Personal Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Enterprise Image Figure 30. Global Enterprise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Third Party Clinical Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Third Party Clinical Testing Market Share by Application 2025 VS 2032 Figure 33. North America Third Party Clinical Testing Market Size Share by Application (2021-2032) Figure 34. Europe Third Party Clinical Testing Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Third Party Clinical Testing Market Size Share by Application (2021-2032) Figure 36. Latin America Third Party Clinical Testing Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Third Party Clinical Testing Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Third Party Clinical Testing Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Third Party Clinical Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Third Party Clinical Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Third Party Clinical Testing Market Share by Country (2021-2032) Figure 43. Europe Third Party Clinical Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Third Party Clinical Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Third Party Clinical Testing Market Share by Country (2021-2032) Figure 46. Asia-Pacific Third Party Clinical Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Third Party Clinical Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Third Party Clinical Testing Market Share by Country (2021-2032) Figure 49. Latin America Third Party Clinical Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Third Party Clinical Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Third Party Clinical Testing Market Share by Country (2021-2032) Figure 52. Middle East & Africa Third Party Clinical Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Third Party Clinical Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Third Party Clinical Testing Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Biochemical Tests
  • Immunity Tests
  • Routine Blood Tests
  • Others
Applications
  • Personal
  • Enterprise
Companies covered
  • Labcorp
  • IQVIA
  • PAREXEL International Corporation
  • ICON Plc
  • Charles River Laboratories
  • Syneos Health
  • PPD (Pharmaceutical Product Development)
  • Medpace
  • WuXi AppTec
  • Kingmed
  • Dian Diagnostics
  • Adicon Clinical Laboratories
  • Kindstar
  • DaAn Gene
  • Berry Genomics
  • Frontage Holdings
  • Centre Testing International
  • Shanghai Labway Clinical Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Third Party Clinical Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Third Party Clinical Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global Third Party Clinical Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global Third Party Clinical Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Third Party Clinical Testing Market Size (2021-2032)
  8. 1.5.1 North America Third Party Clinical Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Third Party Clinical Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Third Party Clinical Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Third Party Clinical Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Third Party Clinical Testing Market Size Growth Rate (2021-2032)
2 Third Party Clinical Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Biochemical Tests
  3. 2.1.2 Immunity Tests
  4. 2.1.3 Routine Blood Tests
  5. 2.1.4 Others
  6. 2.2 Global Third Party Clinical Testing Market Size by Type
  7. 2.2.1 Global Third Party Clinical Testing Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Third Party Clinical Testing Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Third Party Clinical Testing Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Third Party Clinical Testing Market Size by Regions
  11. 2.3.1 North America Third Party Clinical Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Third Party Clinical Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Third Party Clinical Testing Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Third Party Clinical Testing Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Third Party Clinical Testing Market Size Breakdown by Type (2021-2026)
3 Third Party Clinical Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Personal
  3. 3.1.2 Enterprise
  4. 3.2 Global Third Party Clinical Testing Market Size by Application
  5. 3.2.1 Global Third Party Clinical Testing Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Third Party Clinical Testing Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Third Party Clinical Testing Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Third Party Clinical Testing Market Size by Regions
  9. 3.3.1 North America Third Party Clinical Testing Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Third Party Clinical Testing Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Third Party Clinical Testing Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Third Party Clinical Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Third Party Clinical Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Third Party Clinical Testing Industry Trends
  2. 4.2 Third Party Clinical Testing Industry Drivers
  3. 4.3 Third Party Clinical Testing Industry Opportunities and Challenges
  4. 4.4 Third Party Clinical Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Third Party Clinical Testing Revenue (2021-2026)
  2. 5.2 Global Third Party Clinical Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Third Party Clinical Testing Key Company Headquarters & Area Served
  4. 5.4 Global Third Party Clinical Testing Company, Product Type & Application
  5. 5.5 Global Third Party Clinical Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Third Party Clinical Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Third Party Clinical Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Third Party Clinical Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Labcorp
  2. 6.1.1 Labcorp Company Information
  3. 6.1.2 Labcorp Business Overview
  4. 6.1.3 Labcorp Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Labcorp Third Party Clinical Testing Product Portfolio
  6. 6.1.5 Labcorp Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 IQVIA Third Party Clinical Testing Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 PAREXEL International Corporation
  14. 6.3.1 PAREXEL International Corporation Company Information
  15. 6.3.2 PAREXEL International Corporation Business Overview
  16. 6.3.3 PAREXEL International Corporation Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 PAREXEL International Corporation Third Party Clinical Testing Product Portfolio
  18. 6.3.5 PAREXEL International Corporation Recent Developments
  19. 6.4 ICON Plc
  20. 6.4.1 ICON Plc Company Information
  21. 6.4.2 ICON Plc Business Overview
  22. 6.4.3 ICON Plc Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ICON Plc Third Party Clinical Testing Product Portfolio
  24. 6.4.5 ICON Plc Recent Developments
  25. 6.5 Charles River Laboratories
  26. 6.5.1 Charles River Laboratories Company Information
  27. 6.5.2 Charles River Laboratories Business Overview
  28. 6.5.3 Charles River Laboratories Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Charles River Laboratories Third Party Clinical Testing Product Portfolio
  30. 6.5.5 Charles River Laboratories Recent Developments
  31. 6.6 Syneos Health
  32. 6.6.1 Syneos Health Company Information
  33. 6.6.2 Syneos Health Business Overview
  34. 6.6.3 Syneos Health Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Syneos Health Third Party Clinical Testing Product Portfolio
  36. 6.6.5 Syneos Health Recent Developments
  37. 6.7 PPD (Pharmaceutical Product Development)
  38. 6.7.1 PPD (Pharmaceutical Product Development) Company Information
  39. 6.7.2 PPD (Pharmaceutical Product Development) Business Overview
  40. 6.7.3 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product Portfolio
  42. 6.7.5 PPD (Pharmaceutical Product Development) Recent Developments
  43. 6.8 Medpace
  44. 6.8.1 Medpace Company Information
  45. 6.8.2 Medpace Business Overview
  46. 6.8.3 Medpace Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Medpace Third Party Clinical Testing Product Portfolio
  48. 6.8.5 Medpace Recent Developments
  49. 6.9 WuXi AppTec
  50. 6.9.1 WuXi AppTec Company Information
  51. 6.9.2 WuXi AppTec Business Overview
  52. 6.9.3 WuXi AppTec Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 WuXi AppTec Third Party Clinical Testing Product Portfolio
  54. 6.9.5 WuXi AppTec Recent Developments
  55. 6.10 Kingmed
  56. 6.10.1 Kingmed Company Information
  57. 6.10.2 Kingmed Business Overview
  58. 6.10.3 Kingmed Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Kingmed Third Party Clinical Testing Product Portfolio
  60. 6.10.5 Kingmed Recent Developments
  61. 6.11 Dian Diagnostics
  62. 6.11.1 Dian Diagnostics Company Information
  63. 6.11.2 Dian Diagnostics Business Overview
  64. 6.11.3 Dian Diagnostics Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Dian Diagnostics Third Party Clinical Testing Product Portfolio
  66. 6.11.5 Dian Diagnostics Recent Developments
  67. 6.12 Adicon Clinical Laboratories
  68. 6.12.1 Adicon Clinical Laboratories Company Information
  69. 6.12.2 Adicon Clinical Laboratories Business Overview
  70. 6.12.3 Adicon Clinical Laboratories Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Adicon Clinical Laboratories Third Party Clinical Testing Product Portfolio
  72. 6.12.5 Adicon Clinical Laboratories Recent Developments
  73. 6.13 Kindstar
  74. 6.13.1 Kindstar Company Information
  75. 6.13.2 Kindstar Business Overview
  76. 6.13.3 Kindstar Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Kindstar Third Party Clinical Testing Product Portfolio
  78. 6.13.5 Kindstar Recent Developments
  79. 6.14 DaAn Gene
  80. 6.14.1 DaAn Gene Company Information
  81. 6.14.2 DaAn Gene Business Overview
  82. 6.14.3 DaAn Gene Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 DaAn Gene Third Party Clinical Testing Product Portfolio
  84. 6.14.5 DaAn Gene Recent Developments
  85. 6.15 Berry Genomics
  86. 6.15.1 Berry Genomics Company Information
  87. 6.15.2 Berry Genomics Business Overview
  88. 6.15.3 Berry Genomics Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Berry Genomics Third Party Clinical Testing Product Portfolio
  90. 6.15.5 Berry Genomics Recent Developments
  91. 6.16 Frontage Holdings
  92. 6.16.1 Frontage Holdings Company Information
  93. 6.16.2 Frontage Holdings Business Overview
  94. 6.16.3 Frontage Holdings Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Frontage Holdings Third Party Clinical Testing Product Portfolio
  96. 6.16.5 Frontage Holdings Recent Developments
  97. 6.17 Centre Testing International
  98. 6.17.1 Centre Testing International Company Information
  99. 6.17.2 Centre Testing International Business Overview
  100. 6.17.3 Centre Testing International Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Centre Testing International Third Party Clinical Testing Product Portfolio
  102. 6.17.5 Centre Testing International Recent Developments
  103. 6.18 Shanghai Labway Clinical Laboratory
  104. 6.18.1 Shanghai Labway Clinical Laboratory Company Information
  105. 6.18.2 Shanghai Labway Clinical Laboratory Business Overview
  106. 6.18.3 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product Portfolio
  108. 6.18.5 Shanghai Labway Clinical Laboratory Recent Developments
7 North America
  1. 7.1 North America Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Third Party Clinical Testing Market Size by Country (2021-2026)
  3. 7.3 North America Third Party Clinical Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Third Party Clinical Testing Market Size by Country (2021-2026)
  3. 8.3 Europe Third Party Clinical Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Third Party Clinical Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Third Party Clinical Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Third Party Clinical Testing Market Size by Country (2021-2026)
  3. 10.3 South America Third Party Clinical Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Third Party Clinical Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Third Party Clinical Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Third Party Clinical Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst